Home Industries Market Insights About Us Publisher Contact us

Argatroban Market Size By Application(Heparin-induced thrombocytopenia (HIT), Percutaneous Coronary Intervention, Cerebral arterial thrombosis), By Type(Argatroban Powder, Argatroban Injection), By Regional(Europe, America, Asia Pacific, Middle East And Africa), Industry Statistics & Forecast 2020 - 2025

Global Argatroban market Size by Type, End User and Application: Global Opportunity Analysis and Industry Forecast, 2020-2025. The base year considered for the study is 2020, and the forecast has been provided for the period from 2020 to 2025.

Report Summary


Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
In the last several years, global market of Argatroban Industry decreased with the average production growth rate about -15%. In 2015, global capacity of Argatroban reduced to 34786 grams
from 65183 grams since 2011. It is predicted that the argatroban demand will continue to decrease with a average growth rate of -9% in the coming five years.
Japan is the still largest supplier of argatroban with the production market share of 35% and the consumption market share of 22% in 2015.
The price of argatroban is relatively expensive. The largest consumers are developed countries with high income. USA occupied a market share of 34%. The second place is Europe, following North America with the consumption market share of 22% in 2015.
China has few companies entering the market with production share of only 8%, and demand cannot be satisfied with supply. Large quantities of argatroban have to be imported.
Intially, compared with hirudin and heparin, the therapeutic dose has little effect on platelet, no antigen and strong antithrombotic effect. The sale value has reached 190 million USA dollars in 2008. But because of its narrow therapeutic area, uncertain factors on human’s bodies and fierce competition from other substitutes, it sales far less than other thrombin inhibitor. The value reduced to 101 million USA dollars in 2015.
According to this study Argatroban market will register a -14.9% CAGR in terms of revenue, the global market size will reach US$ 32 million by 2025, from US$ 84 million in 2020.
The research report offers an outlook of the attractiveness of the segments and regions, which are formulated based on their growth rate (CAGR) and market size. Argatroban market cost investigation has been performed while keeping in producing costs, overview work cost, and crude materials and their market fixation rate, value pattern and providers. Along with the market position, market share, future trends, market dynamics, threats, opportunities, risks and entry barriers, a complete overview of the Argatroban market is comprised.
Several different factors, for example, supply chain, downstream purchasers, and sourcing methodology have been evaluated to give a top to bottom perspective on the market. Buyer of the report will likewise be presented to an investigation on market positioning with essentials, for example, target customer, brand procedure, and value Technique considered over.
The study report includes the market restrictions and drivers, which may be analyzed from SWOT assessment of the Argatroban market. Major companies and types are taking actions along with stock dispatchers, inclinations, joint endeavors, acquisitions, and forceful research inside the Argatroban market. In the year of 2020, a change was seen inside the CAGR ranges are likewise certain to exchange inside the forecasted year 2020-2025.

Introduction


Rubix Market Research made available a report, which has all company profile the key companies and brands and along with that the report also comprised a synopsis of market trends, definition, classification, and application. The Argatroban market restraints and drivers that are derived from a known method is termed as SWOT analysis. The forecast period 2020-2025 is anticipated to be great for the Argatroban market, which will be the face changer for the Pharmaceuticals and Healthcare industry. The surging users day by day, which is increasing import, sales, revenue, export and CAGR values.

Growth Mapping


The main moto behind this research report is to give a growth map or prospective with respect to activities taken by central members of the Argatroban market like joint endeavors, item dispatches, consolidations, acquisitions, and propensities, which is fueling the Argatroban market and Pharmaceuticals and Healthcare undertaking in overall and furthermore influencing the import, business, income, fare and CAGR values.
The study report conveys the entirety of present realities about market orders, definitions, commitment, and applications for the Argatroban market that are basic to be victorious inside the market. The study report joins the entirety of the organization profiles of the multitude of company’s referred to above. Additionally, clarifying the entirety of the restrictions and drivers of the market with the assistance of SWOT, PESTAL, and Porter’s five forces analysis.

Competitive Landscape


A competitive landscape for the Argatroban market is given in the report. To differentiate business attributes, key players operating in the industry have been profiled and identified. Company overview, financial standings, latest trends, and SWOT are some of the characteristics of major companies in the industry that have been profiled in this study report.
Key companies covered by the study report on the global market are:
Pfizer, Inc
SANDOZ
GlaxoSmithKline Plc
fresenius-kabi
Eagle Pharmaceuticals, Inc
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries Ltd
WEST-WARD,INC
Types covered by the study report on the global market are:
Argatroban Powder
Argatroban Injection
Application covered by the study report on the global market are:
Heparin-induced thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral arterial thrombosis
By Region:
  • North America
    • By Country (US, Canada, Mexico)
    • By Component
    • By System
    • By Application

  • Western Europe
    • By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)
    • By Component
    • By System
    • By Application

  • Eastern Europe
    • By Country (Russia, Turkey, Rest of Eastern Europe)
    • By Component
    • By System
    • By Application

  • Asia Pacific
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Component
    • By System
    • By Application

  • Middle East
    • By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
    • By Component
    • By System
    • By Application

  • Rest of the World
    • By Region (South America, Africa)
    • By Component
    • By System
    • By Application

Report Insights for Argatroban Market
  • Analysis through context of the Argatroban market, which comprises an overall assessment of the parent market.
  • Major trends, drivers, restraints, opportunities, segments and regional markets are studied in this report.
  • Substantial changes in overview and industry dynamics.
  • Argatroban market methods, shares, and approaches of major competitors in the market.
  • Evaluation and reporting of the present industry growths.
  • Current and estimated size of the market, in terms of volume and value both.

The research report provides answers to the following questions:
  • For the Argatroban market what is the anticipated market size and share and growth rate for the forecast period?
  • Who are the major market companies and how they gained a competitive edge over the other companies?
  • What are the major driving and restraining forces of the Argatroban market for the estimated period (2020-2025)?
  • What are the booming Argatroban market opportunities? And how they will support the growth of the market?
  • Which are the market trends influencing the development of the Argatroban

For any other requirements, please feel free to contact us and we will provide you customized report.

Request For TOC

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any), so we can get back to you with a solution
Report Methodology

Request For Discount

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any), so we can get back to you with a solution

FAQ

What is Market Forecast of Global Argatroban market?

The report forecast global Argatroban market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2025.

What Segments are covered in Argatroban Market Research Report?

Types are: , Argatroban Powder, Argatroban Injection, and Application are : , Heparin-induced thrombocytopenia (HIT), Percutaneous Coronary Intervention, Cerebral arterial thrombosis

Who are The Major Players in Argatroban Market?

Key Players for Argatroban Industry : , Pfizer, Inc, SANDOZ, GlaxoSmithKline Plc, fresenius-kabi, Eagle Pharmaceuticals, Inc, Mitsubishi Tanabe Pharma, Teva Pharmaceutical Industries Ltd, WEST-WARD,INC

Can Regional Players Be Added In The Argatroban Market Report?

Yes, you can add top 5 Players or 5 players of your choice per region, as applicable.

Buy Now

Single User

US$ 3880

Multi User

US$ 5450

Corporate User

US$ 7000

WHY RMR?

Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision

Recommendations

Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

Argatroban Market Size By Application(Heparin-indu...